Bispecific CS1-BCMA CAR-T Cells Are Clinically Active in Relapsed or Refractory Multiple Myeloma: An Updated Clinical Study

被引：7
|
作者：
Li, Chenggong [1 ]
Wang, Xindi [1 ]
Wu, Zhuolin [1 ]
Luo, Wenjing [1 ]
Zhang, Yinqiang [1 ]
Kang, Yun [1 ]
Xu, Jia [1 ]
Huang, Zhongpei [1 ]
Du, Mengyi [1 ]
Tang, Lu [1 ]
Wu, Jianghua [1 ]
Liao, Danying [1 ]
Kou, Haiming [1 ]
Lu, Cong [1 ]
Jiang, Huiwen [1 ]
Wei, Qiuzhe [1 ]
Ke, Sha [1 ]
Zheng, Jing'e [1 ]
Xiong, Wei [2 ]
Deng, Jun [1 ]
Hu, Yu [1 ]
Mei, Heng [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Peoples R China
[2] Wuhan Sian Med Technol Co Ltd, Wuhan, Peoples R China
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-170686
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4573 / 4574
页数：2
相关论文
共 50 条
  • [11] Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma
    Eugenia Zah
    Eunwoo Nam
    Vinya Bhuvan
    Uyen Tran
    Brenda Y. Ji
    Stanley B. Gosliner
    Xiuli Wang
    Christine E. Brown
    Yvonne Y. Chen
    Nature Communications, 11
  • [12] Overview of anti-BCMA CAR-T immunotherapy for multiple myeloma and relapsed/refractory multiple myeloma
    Feng, Deming
    Sun, Jian
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2020, 92 (02)
  • [13] Anti-BCMA CAR-T cell immunotherapy for relapsed or refractory multiple myeloma
    Zhang, Xiaohui
    Ouyang, Chenxi
    Sun, Guofeng
    Liu, Hongfeng
    Qi, Junyuan
    Suo, Xiaohui
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (04)
  • [14] Developing a Novel Anti-Bcma CAR-T for Relapsed or Refractory Multiple Myeloma
    Yao, Xin
    Zhu, Shigui
    Huang, Jiaqi
    Qu, Xiaoyan
    Zhu, Judy
    Wei, Yutian
    Lan, Liping
    Lv, Xiaoteng
    Wu, Junfeng
    Wang, Rirfei
    Yang, Dingzhu
    Zheng, Chengxiao
    Zhao, DiJun
    Fan, Lei
    Huang, Fei
    Lu, Hua
    Zhang, Chaocan
    Chen, Cheng
    Li, Yanfeng
    Ren, Jiaqiang
    Zhang, Li
    Humphries, Michael
    Li, Jianyong
    Yao, Yihong
    BLOOD, 2019, 134
  • [15] Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy
    Samer Al Hadidi
    Aniko Szabo
    Jean Esselmann
    Lindsay Hammons
    Munawwar Hussain
    Yetunde Ogunsesan
    Nishanth Thalambedu
    Fatima Khan
    Jaskirat Sethi
    Abhishek Janardan
    Sabarinath Venniyil Radhakrishnan
    Sharmilan Thanendrarajan
    Carolina Schinke
    Binod Dhakal
    Siegfried Janz
    Saurabh Chhabra
    Anita D’Souza
    Maurizio Zangari
    Frits van Rhee
    Meera Mohan
    Bone Marrow Transplantation, 2023, 58 : 443 - 445
  • [16] Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy
    Al Hadidi, Samer
    Szabo, Aniko
    Esselmann, Jean
    Hammons, Lindsay
    Hussain, Munawwar
    Ogunsesan, Yetunde
    Thalambedu, Nishanth
    Khan, Fatima
    Sethi, Jaskirat
    Janardan, Abhishek
    Radhakrishnan, Sabarinath Venniyil
    Thanendrarajan, Sharmilan
    Schinke, Carolina
    Dhakal, Binod
    Janz, Siegfried
    Chhabra, Saurabh
    D'Souza, Anita
    Zangari, Maurizio
    van Rhee, Frits
    Mohan, Meera
    BONE MARROW TRANSPLANTATION, 2023, 58 (04) : 443 - 445
  • [17] Single VHH-directed BCMA CAR-T cells cause remission of relapsed/refractory multiple myeloma
    Lu Han
    Ji-Shuai Zhang
    Jian Zhou
    Ke-Shu Zhou
    Ben-Ling Xu
    Lin-Lin Li
    Bai-Jun Fang
    Qing-Song Yin
    Xing-Hu Zhu
    Hu Zhou
    Xu-Dong Wei
    Hong-Chang Su
    Bing-Xiang Zhang
    Ya-Nan Wang
    Bin Xiang
    Quan-Li Gao
    Yong-Ping Song
    Leukemia, 2021, 35 : 3002 - 3006
  • [18] Single VHH-directed BCMA CAR-T cells cause remission of relapsed/refractory multiple myeloma
    Han, Lu
    Zhang, Ji-Shuai
    Zhou, Jian
    Zhou, Ke-Shu
    Xu, Ben-Ling
    Li, Lin-Lin
    Fang, Bai-Jun
    Yin, Qing-Song
    Zhu, Xing-Hu
    Zhou, Hu
    Wei, Xu-Dong
    Su, Hong-Chang
    Zhang, Bing-Xiang
    Wang, Ya-Nan
    Xiang, Bin
    Gao, Quan-Li
    Song, Yong-Ping
    LEUKEMIA, 2021, 35 (10) : 3002 - 3006
  • [19] CAR-T Therapy in Relapsed Refractory Multiple Myeloma
    Ding, Hong
    Wu, Yu
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (27) : 4362 - 4382
  • [20] Efficacy and Safety of CAR-T Therapy with Safety Switch Targeting Bcma for Patients with Relapsed/Refractory Multiple Myeloma in a Phase 1 Clinical Study
    Fu, Weijun, Sr.
    Du, Juan
    Jiang, Hua
    Cheng, Zhi
    Wei, Runhong
    Yu, Kang
    Jiang, Songfu
    He, Feng
    Fang, Hongliang
    Liu, Yarong
    Wang, Pin
    BLOOD, 2019, 134
12345